241 related articles for article (PubMed ID: 38069266)
21. Metabolism-related gene vaccines and immune infiltration in ovarian cancer: A novel risk score model of machine learning.
Fu Y; Huang Z; Huang J; Xiong J; Liu H; Wan X
J Gene Med; 2024 Jan; 26(1):e3568. PubMed ID: 37455244
[TBL] [Abstract][Full Text] [Related]
22. Integrative Analysis From Multicenter Studies Identifies a WGCNA-Derived Cancer-Associated Fibroblast Signature for Ovarian Cancer.
Feng S; Xu Y; Dai Z; Yin H; Zhang K; Shen Y
Front Immunol; 2022; 13():951582. PubMed ID: 35874760
[TBL] [Abstract][Full Text] [Related]
23. Identification of endoplasmic reticulum stress-associated genes and subtypes for prediction of Alzheimer's disease based on interpretable machine learning.
Lai Y; Lin X; Lin C; Lin X; Chen Z; Zhang L
Front Pharmacol; 2022; 13():975774. PubMed ID: 36059957
[No Abstract] [Full Text] [Related]
24. Prediction of the development of acute kidney injury following cardiac surgery by machine learning.
Tseng PY; Chen YT; Wang CH; Chiu KM; Peng YS; Hsu SP; Chen KL; Yang CY; Lee OK
Crit Care; 2020 Jul; 24(1):478. PubMed ID: 32736589
[TBL] [Abstract][Full Text] [Related]
25. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
Zheng P; Li N; Zhan X
Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
[TBL] [Abstract][Full Text] [Related]
26. Explainable machine learning model for predicting skeletal muscle loss during surgery and adjuvant chemotherapy in ovarian cancer.
Hsu WH; Ko AT; Weng CS; Chang CL; Jan YT; Lin JB; Chien HJ; Lin WC; Sun FJ; Wu KP; Lee J
J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):2044-2053. PubMed ID: 37435785
[TBL] [Abstract][Full Text] [Related]
27. Robust biomarker screening from gene expression data by stable machine learning-recursive feature elimination methods.
Li L; Ching WK; Liu ZP
Comput Biol Chem; 2022 Oct; 100():107747. PubMed ID: 35932551
[TBL] [Abstract][Full Text] [Related]
28. Identification of immune microenvironment subtypes and signature genes for Alzheimer's disease diagnosis and risk prediction based on explainable machine learning.
Lai Y; Lin P; Lin F; Chen M; Lin C; Lin X; Wu L; Zheng M; Chen J
Front Immunol; 2022; 13():1046410. PubMed ID: 36569892
[TBL] [Abstract][Full Text] [Related]
29. A nine-gene signature related to tumor microenvironment predicts overall survival with ovarian cancer.
Ding Q; Dong S; Wang R; Zhang K; Wang H; Zhou X; Wang J; Wong K; Long Y; Zhu S; Wang W; Ren H; Zeng Y
Aging (Albany NY); 2020 Mar; 12(6):4879-4895. PubMed ID: 32208363
[TBL] [Abstract][Full Text] [Related]
30. Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer.
Fei H; Han X; Wang Y; Li S
J Ovarian Res; 2023 Oct; 16(1):205. PubMed ID: 37858138
[TBL] [Abstract][Full Text] [Related]
31. A machine learning model based on ultrasound image features to assess the risk of sentinel lymph node metastasis in breast cancer patients: Applications of scikit-learn and SHAP.
Zhang G; Shi Y; Yin P; Liu F; Fang Y; Li X; Zhang Q; Zhang Z
Front Oncol; 2022; 12():944569. PubMed ID: 35957890
[TBL] [Abstract][Full Text] [Related]
32. Deciphering the endometrial immune landscape of RIF during the window of implantation from cellular senescence by integrated bioinformatics analysis and machine learning.
Zhao X; Zhao Y; Jiang Y; Zhang Q
Front Immunol; 2022; 13():952708. PubMed ID: 36131919
[TBL] [Abstract][Full Text] [Related]
33. A Machine-Learning Approach to Developing a Predictive Signature Based on Transcriptome Profiling of Ground-Glass Opacities for Accurate Classification and Exploring the Immune Microenvironment of Early-Stage LUAD.
Zhao Z; Yin W; Peng X; Cai Q; He B; Shi S; Peng W; Tu G; Li Y; Li D; Tao Y; Peng M; Wang X; Yu F
Front Immunol; 2022; 13():872387. PubMed ID: 35693786
[TBL] [Abstract][Full Text] [Related]
34. Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer.
Liu Q; Yang X; Yin Y; Zhang H; Yin F; Guo P; Zhang X; Sun C; Li S; Han Y; Yang Z
Oxid Med Cell Longev; 2022; 2022():6575534. PubMed ID: 36561981
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and Prediction of Endometrial Carcinoma Using Machine Learning and Artificial Neural Networks Based on Public Databases.
Zhao D; Zhang Z; Wang Z; Du Z; Wu M; Zhang T; Zhou J; Zhao W; Meng Y
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741697
[TBL] [Abstract][Full Text] [Related]
36. Potential Prognostic Immune Biomarkers of Overall Survival in Ovarian Cancer Through Comprehensive Bioinformatics Analysis: A Novel Artificial Intelligence Survival Prediction System.
He T; Huang L; Li J; Wang P; Zhang Z
Front Med (Lausanne); 2021; 8():587496. PubMed ID: 34109184
[No Abstract] [Full Text] [Related]
37. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
[TBL] [Abstract][Full Text] [Related]
38. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
39. Machine learning developed a fibroblast-related signature for predicting clinical outcome and drug sensitivity in ovarian cancer.
Fu W; Feng Q; Tao R
Medicine (Baltimore); 2024 Apr; 103(16):e37783. PubMed ID: 38640321
[TBL] [Abstract][Full Text] [Related]
40. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
